Case studies, Healthtech and biotech
Pitch decks and product design for healthtech and biotech.
Science does not sell itself to people who fund it. We turn mechanisms, trial data and clinical workflows into slides that a generalist investor understands and a specialist respects.
What investors and buyers check first
- The science in one clear picture before any data
- Clinical and regulatory path: stages, timelines and what each milestone unlocks
- Who pays: reimbursement, pricing and the buyer inside a health system
- Evidence so far, shown with the right caveats rather than overstated
What we build for you
- Mechanism of action and platform diagrams drawn from your papers and notes
- Pipeline, trial and milestone slides that stay readable at a glance
- Clinical workflow and product screens for digital health tools
- Partner and pharma versions of the deck alongside the investor version
Healthtech and biotech work
- Caresyntax: a technical guide people can navigate: A technical integration guide for a digital surgery platform, written for healthcare organisations and technology partners.
- ClaimLynk: making a claims workflow obvious: A support and services presentation for a third-party administrator, built around the flow of a claim.
- Reflector Bio: explaining AI drug discovery to people who fund it: A deck about AI-driven drug discovery, built so the science lands with an audience that is not in the lab.
- Hygia Health: a healthcare deck with the patient in it: A healthcare presentation built around the patient journey rather than the org chart.
- Healthians: diagnostics made plain: Presentation design for a diagnostics business, with the service explained before the numbers arrive.
- AI-Enhanced Workflow: a healthcare one-pager that has one page to work in: A single page explaining an AI-assisted clinical workflow, for a reader who will give it a minute.
Questions
Do we need to explain the science to you first?
A 30 minute call and your existing material is usually enough. We ask questions until the slide is accurate, and your team signs off every scientific claim.
Can you make one deck work for investors and pharma partners?
Usually it works better as two versions from one system: the same science, different emphasis. We build both from the same master file.
Is our unpublished data safe with you?
Yes. We sign an NDA on request, and confidential work never goes in our portfolio.